Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial by Bain, Stephen C., Mosenzon, Ofri, Arechavaleta, Rosario, Bogdański, Pawel, Comlekci, Abdurrahman, Consoli, Agostino, Deerochanawong, Chaicharn, Dungan, Kathleen, Faingold, Maria C., Farkouh, Michael E., Franco, Denise R., Gram, Jeppe, Guja, Cristian, Joshi, Pankaj, Malek, Rachid, Merino‐Torres, Juan F., Nauck, Michael A., Pedersen, Sue D., Sheu, Wayne H. ‐H., Silver, Robert J., Tack, Cees J., Tandon, Nikhil, Jeppesen, Ole K., Strange, Mette, Thomsen, Mette, Husain, Mansoor

Get full text

Diet only or diet and sulfonylureas in mild type II diabetes (niddm)? Pathophysiologic and therapeutic implications by Sinay, Isaac R., Arias, Pablo, Schnitman, Marta A., Damilano, Sergio A., Faingold, Maria C., Moguilevsky, Jaime A.

Get full text

Differential Profile of Ultrasound Findings Associated with Malignancy in Mixed and Solid Thyroid Nodules in an Elderly Female Population by Grisendi, Silvio, Serrano, María Sol, Serrano, Leonardo, Zuk, Carlos, De Barrio, Guillermo, Cejas, Claudia, Faingold, María Cristina, Brenta, Gabriela, Brites, Fernando, Schnitman, Marta, Rosmarin, Melanie, Morosan, Yanina, Parisi, Carina, Urrutia, María Agustina, Meroño, Tomás, Vera, María Inés, Luciani, Wilfredo

Get full text

Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction... by Gerstein, Hertzel, Yusuf, Salim, Riddle, Matthew C, Ryden, Lars, Bosch, Jackie

Get full text